Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2007
10/23/2007US7285628 PRO1867 polypeptides
10/23/2007US7285627 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
10/23/2007US7285622 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides
10/23/2007US7285621 Multiple branch peptide construction
10/23/2007US7285620 For selective modulation of leukocyte function, which is useful in a variety of inflammatory and autoimmune diseases, or in therapy of infections
10/23/2007US7285619 E.g, 1-([-4-oxo-N2-(12-methyl-1-oxotetradecyl)-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B and 1-[N2-[[4'-octyloxy)-[1,1'-biphenyl]-4-yl]-carbonyl]-4-oxo-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B
10/23/2007US7285618 Polypeptides having neutrophil stimulating activity
10/23/2007US7285580 Methods of using primer molecules for enhancing the mechanical performance of tissue adhesives and sealants
10/23/2007US7285551 For use as therapeutic agent and prophylactic agent for hepatitis C
10/23/2007US7285541 Antisense treatments for melanoma by inhibition of clusterin, also known as testosterone-repressed prostate message-2, for example by administration of antisense oligonucleotides specific for clusterin
10/23/2007US7285540 hepatocyte growth factor gene as drug; topical applying ; side effect reduction; cardiovascular disorders
10/23/2007US7285537 Oligonucleotide therapeutic agent and methods of making same
10/23/2007US7285535 Administering TIRAP to block Toll/Interleukin-1 Receptor Adaptor Protein signaling in a cell; for treatment of inflammation and inducing or affecting immune response.
10/23/2007US7285534 Corticotropin-releasing hormone analogs and their uses
10/23/2007US7285533 Using cytokine agent to induce apoptosis in tissues demonatrating abnormal cell proliferation; antitumor agents; tissue targeted therapy
10/23/2007US7285532 Therapeutic method for treating bone formation diseases
10/23/2007US7285531 Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor
10/23/2007US7285528 Peptide antagonists of GnRH-2 that bind to GnRH-2 receptors; useful for the treatment of reproductive diseases and steroid-related cancers
10/23/2007US7285527 Tumor radiosensitization using gene therapy
10/23/2007US7285526 Reducing the interferon-bioavailability by administering two isolated interferon-binding proteins, e.g., the human IFN-gamma receptor; B8R and B18R proteins of Vaccinia virus; Alzheimer's disease; Down syndrome; HIV; autoimmune diseases
10/23/2007US7285525 Suppression of immune response via inhibition of cathepsin S
10/23/2007US7285524 Allo and auto-reactive T-cell epitopes
10/23/2007US7285408 for treating respiratory disorders; for producing a catalytic domain of a zinc metalloprotease; genetic engineering
10/23/2007US7285400 High bone mass gene of 11q13.3
10/23/2007US7285398 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders
10/23/2007US7285390 Screening methods for identifying compounds which decrease HIV entry into a cell
10/23/2007US7285282 Mucin peptide with immunoenhancing properties
10/23/2007US7285279 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/23/2007US7285277 Administering LK6/68 proteins in which sequence is identical to apolipoprotein kringle domains to reduce tumor growth; recombinant Escherichia; for treatment of cancer, rheumatoid arthritis, and psoriasis
10/23/2007US7285276 Polynucleotide sequence for Chlamydia pneumonia; therapy, prevention of Chlamydia infections
10/23/2007US7285275 Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor
10/23/2007US7285267 Antiinflammatory agents
10/23/2007US7285264 Triblock peptide, high affinity to body surfaces, such as, hair, skin, nails, teeth, gums, and oral cavity surfaces
10/23/2007CA2391098C Recombinant .alpha.-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/23/2007CA2272130C Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
10/23/2007CA2271697C Tissue type plasminogen activator (t-pa) variants: compositions and methods of use
10/23/2007CA2263889C P-selectin ligand proteins
10/23/2007CA2244209C Improved concentrated injection and infusion solutions for intravenous administration
10/23/2007CA2216250C Casein phosphopeptide, casein containing same and process for the preparation thereof
10/23/2007CA2206179C Vectors for tissue-specific replication
10/23/2007CA2191612C A process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same
10/23/2007CA2181910C Process for making avermectin/zein compositions
10/23/2007CA2155630C Low temperature albumin fractionation using sodium caprylate as a partitioning agent
10/20/2007CA2541903A1 A method of diagnosis and treatment
10/18/2007WO2007118136A2 Method for creating a stratigraphic model using pseudocores created from borehole images
10/18/2007WO2007118051A2 Lipid therapy
10/18/2007WO2007117469A2 Compositions of less immunogenic and long-circulating protein-lipid complexes
10/18/2007WO2007117467A2 Use of tm-601 for the diagnosis and treatment of tumors
10/18/2007WO2007117451A2 A pericellular collagenase directs the 3-dimensional development of white adipose tissue
10/18/2007WO2007117215A1 Binder for c-reactive protein
10/18/2007WO2007117173A1 Fluid dispensing system, methods and products
10/18/2007WO2007116965A1 Fine particle containing graft polymer and calcium compound
10/18/2007WO2007116925A1 hCL-K1 POLYPEPTIDE HAVING COLLECTIN ACTIVITY
10/18/2007WO2007116632A1 Microparticles, microparticle dispersion and method and apparatus for producing the same
10/18/2007WO2007116458A1 Therapeutic agent for neurodegenerative disease
10/18/2007WO2007116428A2 Oral pharmaceutical composition containing cystine or cysteine with glutathione against oxidative stress resulting from haemodialysis
10/18/2007WO2007116410A2 Livestock management for improved reproductive efficiency
10/18/2007WO2007116278A2 Antiangiogenic peptide and therapeutic uses thereof
10/18/2007WO2007116276A2 Integrin binding rgd-lipopeptides with gene transfer activities
10/18/2007WO2007116114A1 Use of delta opioid receptor agonists in the preparation of pharmaceutical compositions, pharmaceutical compositions that contain them and their applications in the treatment of tumours
10/18/2007WO2007116091A1 Novel nutraceutical compositions
10/18/2007WO2007115953A1 Covalent factor vii-tissue factor complex
10/18/2007WO2007115726A2 The homeobox transcription factor bsx and uses thereof for treating diseases, in particular obesity
10/18/2007WO2007115571A2 Erbb receptor-derived peptide fragments
10/18/2007WO2007115414A1 Modified h2 relaxin for tumor suppression
10/18/2007WO2007115376A1 Anti-angiogenic agents and methods of their use
10/18/2007WO2007099227A3 Use of the engrailed homeodomain protein as an anxiolytic
10/18/2007WO2007098417A3 Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor
10/18/2007WO2007096596A3 Use of il-8 for the treatment of crohn' s disease
10/18/2007WO2007092829A3 Stabilized compositions of proteins having a free thiol moiety
10/18/2007WO2007087524A3 Treatment of acute respiratory distress syndrome
10/18/2007WO2007085611A3 Colony stimulating factors for the treatment of coma and neurotoxicity
10/18/2007WO2007083323A3 Modified release oral dosage form comprising desmopressin
10/18/2007WO2007083246A3 Vegf variants
10/18/2007WO2007064634A3 Enterostatin as inhibitor of angiogenesis
10/18/2007WO2007062000A3 Fibroblast growth factor-5 and uses thereof
10/18/2007WO2007061922A3 Methods to predict and prevent resistance to taxoid compounds
10/18/2007WO2007054600B1 Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination
10/18/2007WO2007041240A3 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
10/18/2007WO2007035494A3 Inducing expression of puma to reduce joint inflammation in the treatment of arthritis
10/18/2007WO2007024574A3 Topical formulations of histone deacetylase inhibitors and methods of using the same
10/18/2007WO2007011265A8 Method for blocking noggin2 target specific activities
10/18/2007WO2007001335A3 Ramoplanin derivatives possessing antibacterial activity
10/18/2007WO2005081628A3 Casein derived peptides and therapeutic uses thereof
10/18/2007WO2002089833A3 Methods and compositions for prevention of angioproliferation
10/18/2007WO2002010354A3 Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin 2)
10/18/2007WO2002010198A3 Polynucleotides and polypeptides
10/18/2007WO2001030974A3 Molecules targeting cd40 which do not activate cd40-expressing cells
10/18/2007US20070244299 Method of Stabilizing Proteins
10/18/2007US20070244063 Inducing angiogenesis comprising contacting endothelial cells expressing Bv8 receptor with a polypeptide comprising the amino acid sequence of SEQ ID NO:2; using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival; screening for Bv8 modulators
10/18/2007US20070244057 Suppressing polyglutamine aggregation and toxicity
10/18/2007US20070244056 Combination Therapy With Glatiramer Acetate and Riluzole
10/18/2007US20070244055 Conjugates useful in the treatment of prostate cancer
10/18/2007US20070244054 Peptides for use in treating obesity
10/18/2007US20070244053 Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejection
10/18/2007US20070244052 Methods for Identifying Agonists or Antagonists of CD200R Signaling Molecules and Methods of Using the Same
10/18/2007US20070244051 Side effect reduction; latanoprost; it is believed that TFF-peptides may be present during healing and other related processes in the eye
10/18/2007US20070244050 Peptides as solubilizing excipients for transforming growth factor beta proteins
10/18/2007US20070244049 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
10/18/2007US20070244048 Neuromedin U receptor agonists and uses thereof
1 ... 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 ... 3163